Fofanova O V, Takamura N, Kinoshita E, Yoshimoto M, Tsuji Y, Peterkova V A, Evgrafov O V, Dedov I I, Goncharov N P, Yamashita S
Department of Pediatrics, Research Center for Medical Genetics, Moscow, Russia.
Am J Med Genet. 1998 Jun 5;77(5):360-5. doi: 10.1002/(sici)1096-8628(19980605)77:5<360::aid-ajmg4>3.0.co;2-r.
To ascertain the molecular background of combined pituitary hormone deficiency, screening for mutations in the pituitary-specific transcription factor (Pit-1/GHF-1) gene (PIT1) was performed on a cohort of 15 children from Russia with combined growth hormone (GH)/prolactin (Prl)/thyroid-stimulating hormone (TSH) deficiency. The group of patients, suspected of PIT1 mutations, consisted of four familial cases (seven patients) and eight sporadic cases. All had complete GH deficiency and complete or partial Prl and TSH deficiency. Direct sequencing of all six exons of PIT1 and its promoter region showed a C to T transition mutation at codon 14 of exon 1 in a 3 8/12-year-old girl. This novel PIT1 mutation results in a proline to leucine substitution (P14L). The patient was heterozygous for mutant and normal alleles. The heterozygous P14L mutation was also present in her mother as well as in her maternal aunt and grandmother, all of whom were phenotypically normal. There was no mutation in the father's DNA, suggesting the need for reevaluation of genomic imprinting. In other children of our series, no mutation in PIT1 or in its promotor region was identified. This is the first report on the analysis of PIT1 and its promoter region in Russian children with GH/Prl/TSH deficiency. However, as the involvement of PIT1 mutation is rare in Russia, the other negative cases need to be analyzed for another candidate gene responsible for combined GH/Pr/TSH deficiency.
为了确定联合垂体激素缺乏症的分子背景,我们对来自俄罗斯的15名生长激素(GH)/催乳素(Prl)/促甲状腺激素(TSH)联合缺乏的儿童进行了垂体特异性转录因子(Pit-1/GHF-1)基因(PIT1)突变筛查。疑似PIT1突变的患者组包括4个家族性病例(7名患者)和8个散发性病例。所有患者均有完全性生长激素缺乏以及完全或部分性催乳素和促甲状腺激素缺乏。对PIT1的所有6个外显子及其启动子区域进行直接测序,结果显示一名3又8/12岁女孩的外显子1第14密码子处存在C到T的转换突变。这个新的PIT1突变导致脯氨酸被亮氨酸取代(P14L)。该患者的突变等位基因和正常等位基因呈杂合状态。杂合的P14L突变也存在于她的母亲、外祖母和姨母中,她们在表型上均正常。父亲的DNA未发现突变,这表明需要重新评估基因组印记。在我们研究系列中的其他儿童中,未发现PIT1或其启动子区域存在突变。这是关于俄罗斯生长激素/催乳素/促甲状腺激素缺乏儿童PIT1及其启动子区域分析的首篇报道。然而,由于俄罗斯PIT1突变的发生率较低,其他阴性病例需要分析另一个导致生长激素/催乳素/促甲状腺激素联合缺乏的候选基因。